Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.

Holtmeier, Wolfgang; Zeuzem, Stefan; Preiss, Jan; Kruis, Wolfgang; Böhm, Stephan; Maaser, Christian; Raedler, Andreas; Schmidt, Carsten; Schnitker, Jörg; Schwarz, Joachim; Zeitz, Martin; Caspary, Wolfgang

Holtmeier, Wolfgang; Zeuzem, Stefan; Preiss, Jan; Kruis, Wolfgang; Böhm, Stephan; Maaser, Christian; Raedler, Andreas; Schmidt, Carsten; Schnitker, Jörg; Schwarz, Joachim; Zeitz, Martin; Caspary, Wolfgang.

Affiliation

Holtmeier W; Department of Gastroenterology, Diabetes and Internal Medicine, Hospital Porz am Rhein, Cologne, Germany. W.Holtmeier@khporz.de

Inflamm Bowel Dis ; 17(2): 573-82, 2011 Feb.

Article in En | MEDLINE | ID: mdl-20848527

Subject(s)

Boswellia/chemistry; Crohn Disease/drug therapy; Phytotherapy; Plant Extracts/therapeutic use; Adult; Aged; Double-Blind Method; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Remission Induction; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Plant Extracts / Crohn Disease / Boswellia / Phytotherapy Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2011 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google